Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Farnese, , Gastone,
DOB: 16-APR-1939 (Age: 86)
Gender: male
Address:
Rotonda Verdone, 9 Appartamento 6
35030 Galzignano Terme (Italy)
ID: 9783-008691-0 (ECI)
Report
Date: 01-JAN-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ospedali Riuniti Padova Sud "Madre Teresa di Calcutta"
Via Albere nan
35042 Este (Italy)
Specimen
Collected: 31-DEC-2022

Chemistry

Test 01-JAN-2023 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 117.6 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 117.0 0 - 199 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 36.3 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.8 40 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All lipid parameters (total cholesterol, triglycerides, LDL, and HDL) are within normal limits. No laboratory evidence of dyslipidemia at this time. Continue routine monitoring as clinically indicated.